scholarly journals Systematic Review: Components of a Comprehensive Geriatric Assessment in Inflammatory Bowel Disease—A Potentially Promising but Often Neglected Risk Stratification

2019 ◽  
Vol 13 (11) ◽  
pp. 1418-1432 ◽  
Author(s):  
Vera E R Asscher ◽  
Felicia V Y Lee-Kong ◽  
Esther D Kort ◽  
Floor J van Deudekom ◽  
Simon P Mooijaart ◽  
...  

Abstract Background The population of older patients with inflammatory bowel disease [IBD] is increasing. Patient age does not fully account for poor outcomes and its clinical utility for risk stratification is limited. Comprehensive geriatric assessment [CGA], comprising a somatic, functional, mental, and social assessment or frailty, could be a predictor tool. Aims To systematically review literature on the kind of components of a CGA being used in adult IBD patients and the association of these components with adverse health outcomes. Methods An electronic literature search was performed on January 16, 2018, using PubMed, Embase, Web of Science, the Cochrane Library, CENTRAL, Emcare, and PsycINFO. Longitudinal studies relating somatic, functional, mental, and social assessment or frailty to adverse health outcomes during follow-up in IBD patients were included. The Newcastle-Ottawa scale was used to assess individual study quality. Results Of 4080 identified citations, 27 studies were included, reporting 169 associations. Median sample size was 108 patients (interquartile range [IQR] 60–704). No studies performed subgroup analyses on older patients, and the highest mean age reported was 52.7 years. Somatic and functional assessments were used in three studies, mental in 24, and social in five. No study assessed cognitive status, functional performance, or frailty. In 62 associations [36.7%], components of a CGA were significantly associated with adverse health outcome measurements. Conclusions Components of a CGA were associated with adverse health outcomes in IBD patients, but older patients were under-represented. More studies among older patients with IBD are warranted to further establish the clinical impact of a CGA.

Author(s):  
Vera E.R. Asscher ◽  
Sanne N. Waars ◽  
Andrea E. van der Meulen-de Jong ◽  
Rogier J.L. Stuyt ◽  
A. Martine C. Baven-Pronk ◽  
...  

Gut ◽  
2020 ◽  
pp. gutjnl-2019-319129
Author(s):  
Shannon Linda Kanis ◽  
Sanne Modderman ◽  
Johanna C Escher ◽  
Nicole Erler ◽  
Ruud Beukers ◽  
...  

ObjectiveThe aim of this study was to describe the long-term health outcomes of children born to mothers with inflammatory bowel disease (IBD) and to assess the impact of maternal IBD medication use on these outcomes.DesignWe performed a multicentre retrospective study in The Netherlands. Women with IBD who gave birth between 1999 and 2018 were enrolled from 20 participating hospitals. Information regarding disease characteristics, medication use, lifestyle, pregnancy outcomes and long-term health outcomes of children was retrieved from mothers and medical charts. After consent of both parents, outcomes until 5 years were also collected from general practitioners. Our primary aim was to assess infection rate and our secondary aims were to assess adverse reactions to vaccinations, growth, autoimmune diseases and malignancies.ResultsWe included 1000 children born to 626 mothers (381 (61%) Crohn’s disease, 225 (36%) ulcerative colitis and 20 (3%) IBD unclassified). In total, 196 (20%) had intrauterine exposure to anti-tumour necrosis factor-α (anti-TNF-α) (60 with concomitant thiopurine) and 240 (24%) were exposed to thiopurine monotherapy. The 564 children (56%) not exposed to anti-TNF-α and/or thiopurine served as control group. There was no association between adverse long-term health outcomes and in utero exposure to IBD treatment. We did find an increased rate of intrahepatic cholestasis of pregnancy (ICP) in case thiopurine was used during the pregnancy without affecting birth outcomes and long-term health outcomes of children. All outcomes correspond with the general age-adjusted population.ConclusionIn our study, we found no association between in utero exposure to anti-TNF-α and/or thiopurine and the long-term outcomes antibiotic-treated infections, severe infections needing hospital admission, adverse reactions to vaccinations, growth failure, autoimmune diseases and malignancies.


2009 ◽  
Vol 44 (5) ◽  
pp. 485-492 ◽  
Author(s):  
Sian Cotton ◽  
Ian Kudel ◽  
Yvonne Humenay Roberts ◽  
Harini Pallerla ◽  
Joel Tsevat ◽  
...  

2017 ◽  
Vol 112 ◽  
pp. S79-S80
Author(s):  
Shirley Cohen-Mekelburg ◽  
Yecheskel Schneider ◽  
Stephanie Gold ◽  
Gaurav Ghosh ◽  
Russell Rosenblatt ◽  
...  

2017 ◽  
Vol 112 ◽  
pp. S370
Author(s):  
Akriti Saxena ◽  
Bethany H T. Miller ◽  
Ashley S. Freyre ◽  
Alessandra Sorrentino ◽  
Michelle Long ◽  
...  

1994 ◽  
Vol 78 (6) ◽  
pp. 1303-1319 ◽  
Author(s):  
Deborah E. Fleischer ◽  
Ian S. Grimm ◽  
Lawrence S. Friedman

Sign in / Sign up

Export Citation Format

Share Document